{"ResultsReport": {"ResultsPayload": {"FinalReport": {"Sample": {"FM_Id": null, "SampleId": null, "BlockId": "nan", "TRFNumber": null, "TestType": "Oncomine Myeloid Assay", "SpecFormat": "Bone Marrow", "ReceivedDate": "2023/08/16", "TumorPurity": "nan", "SpecimenLocation": "nan"}, "PMI": {"ReportId": "M112-00217", "MRN": "26974732", "FullName": "\u5433\u8000\u76db", "FirstName": null, "LastName": null, "SubmittedDiagnosis": "Chronic myeloid leukemia in blast phase is more appropriate _x000D_\n(2022 WHO and 2022 ICC) as history of leukocytosis for 2 years, _x000D_\nand concurrent BCR::ABL1 and MECOM rearrangement are found in _x000D_\nthe assay.", "Gender": "Male", "DOB": null, "OrderingMD": "\u6797\u5ead\u5b89", "OrderingMDId": "DOC8127E", "Pathologist": "\u694a\u975c\u82ac", "CopiedPhysician1": null, "MedFacilName": null, "MedFacilID": null, "SpecSite": null, "CollDate": null, "ReceivedDate": "2023-08-17 00:00:00", "CountryOfOrigin": null, "TumorType": "Chronic Myeloid Leukemia"}}, "variant_report": {"short_variants": null, "copy_number_alterations": null, "rearrangements": {"rearrangement": {"description": null, "equivocal": null, "in_frame": null, "other_gene": "RUNX1_MECOM.R4M2", "pos1": "chr21:36206707_chr3:169099312", "pos2": null, "status": null, "supporting_read_pairs": "6863", "targeted_gene": "RUNX1_MECOM", "type": null, "dna_evidence": {"sample": null}}}, "biomarkers": {"microsatellite_instability": {"status": null}, "tumor_mutation_burden": {"score": null}}}}}}